SUNZEN BIOTECH BHD
KLSE (MYR): SUNZEN (0148)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.315
Today's Change
+0.005 (1.61%)
Day's Change
0.305 - 0.315
Trading Volume
733,000
Entitlement
Upcoming
Happening
| Ann. Date | Ex Date | Type | Subject | Amount |
|---|
Discussions
5 people like this. Showing 50 of 2,230 comments
Strong growth every quarter, Sunzen future prospect is really bright with new acquisition
2024-08-09 16:10
Next quarter's revenue and net profit will both increase quarter-on-quarter and year-on-year, I believe
2024-08-12 20:08
Sunzen has decreased current liabilities to 6.3% of total assets over this period. Good sign
2024-08-13 16:15
I just watched it. Must say the new management seems to be doing the right thing compare to the previous one. At least now SUNZEN is no longer losing money but making profit
2024-09-23 10:20
Hopes the Xmegami lenglui will buy in sunzen also since their earning so high every month
2 months ago
Watched the technical analysis here https://youtu.be/9V0_mkxG1sw?si=M-l0iuIJeU4w9q5Q
2 months ago
Dow Jones
Dow Jones Industrial Average
42,011.59
-184.93
0.43%
Nasdaq
NASDAQ Composite
17,918.47
-6.64
0.03%
2 months ago
Share price still steady after that, biggie0000. We wait for the next rally to come
1 month ago
As consumers pay more and more attention to preventive health care and natural remedies, Sunzen's traditional Chinese medicine and human health supplement products have huge growth potential
1 month ago
Nice grab, gloveshapiro. If the QR is good as expected, it probably will break 35 cents
1 month ago
Sunzen Biotech eyes bigger share of China bird’s nest market. Sunzen subsidiary Ecolite Biotech Manufacturing Sdn Bhd has received approval from China’s customs authority in October last year to export its bottled bird’s nest to the country up to 2028.
1 month ago
The demand for edible bird’s nest products is indeed strong in China, Hong Kong, and other parts of Southeast Asia. The Chinese market, in particular, is one of the largest consumers of bird’s nests, driven by a cultural preference for traditional health products and rising disposable incomes
1 month ago
Sunzen's loan financing business is expected to continue to grow given the increasing trend in the number of applications and approvals, mainly due to our ability to provide fast and efficient services and structure more flexible loan packages to meet the needs of the SME market.
1 month ago
Acquisition of Eye Nation Medical is expected to contribute positively to the future financial performance of the Sunzen group, enhancing the group’s revenue and profitability, as it is secured by a profit guarantee of an audited profit after tax of RM2.60 million over the next two financial years
1 month ago
Then SUNZEN will be able to achieve over RM1 million of net profit in the next quarter 😀
1 month ago
more expansion into the healthcare sector, Sunzen keep building & growing... TP 0.40
1 month ago
QR was out, the company reported revenue of RM22.96 million and PBT of RM0.86 million. In the current quarter, human health products and loan financing accounted for 76.85% and 14.26%, respectively, while the remaining 8.89% came from the animal health business.
1 month ago
why so sour, eye nation & ecolite biotech will start bringin in more profit next quarter
4 weeks ago
Malaysia is one of the world’s largest producers of bird’s nest, with a significant portion of its production exported to China, where demand remains robust. Maintain a "buy" rating on Sunzen
3 weeks ago
SUNZEN GROUP BERHAD SEES SHAREHOLDERS SUPPORT IN AGM WITH APPROVAL IN ALL 9 RESOLUTIONS
6 days ago
Post a Comment
Featured Posts
Latest Videos
MQ Trading Signals
Time
Signal
Duration
Type
2024-12-26 14:40:00
TURTLE SYSTEM 20
5 Mins
BUY
2024-12-26 14:40:00
TURTLE SYSTEM 55
5 Mins
BUY
2024-12-26 12:30:00
EMA 5
5 Mins
BUY
2024-12-26 11:45:00
ADX
5 Mins
BUY
Apps
Top Articles
1
2
3
Koon Yew Yin's Blog
4
THE INVESTMENT APPROACH OF CALVIN TAN
5
M+ Online Research Articles
6
TA Sector Research
7
Mercury Securities Research
8
Mercury Securities Research
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
gloveshapiro
0.31-0.32 is a steady & cheap entry price now, Sunzen entering the healthcare sector will push the price further up
2024-08-08 15:07